SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,400,000 | +6.9% | 32,706 | -7.2% | 0.33% | -1.2% |
| Q2 2020 | $5,987,000 | +68.7% | 35,232 | +14.6% | 0.33% | +25.2% |
| Q1 2020 | $3,548,000 | -23.7% | 30,748 | -24.5% | 0.27% | +31.0% |
| Q4 2019 | $4,652,000 | +109.3% | 40,712 | +56.4% | 0.20% | +81.2% |
| Q3 2019 | $2,223,000 | +20.6% | 26,036 | -2.2% | 0.11% | +28.7% |
| Q2 2019 | $1,843,000 | -16.0% | 26,624 | -11.2% | 0.09% | -17.9% |
| Q1 2019 | $2,195,000 | +31.5% | 29,973 | +1.8% | 0.11% | +2.9% |
| Q4 2018 | $1,669,000 | -40.5% | 29,456 | -19.0% | 0.10% | -2.8% |
| Q3 2018 | $2,806,000 | +28.3% | 36,381 | +10.4% | 0.11% | +21.8% |
| Q2 2018 | $2,187,000 | +19.0% | 32,947 | -6.2% | 0.09% | +19.2% |
| Q1 2018 | $1,838,000 | -2.9% | 35,115 | -0.8% | 0.07% | 0.0% |
| Q4 2017 | $1,893,000 | -12.3% | 35,382 | -10.8% | 0.07% | -18.9% |
| Q3 2017 | $2,159,000 | +12.9% | 39,678 | +7.4% | 0.09% | +3.4% |
| Q2 2017 | $1,912,000 | -22.9% | 36,957 | -6.4% | 0.09% | -21.6% |
| Q1 2017 | $2,481,000 | +10.6% | 39,469 | -7.2% | 0.11% | +7.8% |
| Q4 2016 | $2,244,000 | -15.1% | 42,529 | -13.1% | 0.10% | -18.3% |
| Q3 2016 | $2,643,000 | +12.3% | 48,937 | -16.0% | 0.13% | +9.6% |
| Q2 2016 | $2,354,000 | +10.2% | 58,256 | -4.3% | 0.12% | +3.6% |
| Q1 2016 | $2,136,000 | -36.9% | 60,872 | -19.3% | 0.11% | -31.1% |
| Q4 2015 | $3,384,000 | +17.4% | 75,392 | +0.9% | 0.16% | -1.8% |
| Q3 2015 | $2,883,000 | -21.1% | 74,755 | -1.0% | 0.16% | +8.6% |
| Q2 2015 | $3,656,000 | +36.9% | 75,536 | -0.0% | 0.15% | +45.2% |
| Q1 2015 | $2,671,000 | +18.8% | 75,550 | +8.0% | 0.10% | +13.0% |
| Q4 2014 | $2,248,000 | -3.2% | 69,960 | +12.0% | 0.09% | -15.6% |
| Q3 2014 | $2,322,000 | -8.6% | 62,454 | -6.0% | 0.11% | -1.8% |
| Q2 2014 | $2,541,000 | -33.7% | 66,430 | -21.0% | 0.11% | -36.2% |
| Q1 2014 | $3,832,000 | +40.5% | 84,112 | +23.0% | 0.17% | +42.6% |
| Q4 2013 | $2,727,000 | +16.9% | 68,369 | +28.5% | 0.12% | -1.6% |
| Q3 2013 | $2,332,000 | +51.2% | 53,214 | +8.5% | 0.12% | +13.8% |
| Q2 2013 | $1,542,000 | – | 49,025 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |